Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

  1. Condorelli, R.
  2. Mosele, F.
  3. Verret, B.
  4. Bachelot, T.
  5. Bedard, P.L.
  6. Cortes, J.
  7. Hyman, D.M.
  8. Juric, D.
  9. Krop, I.
  10. Bieche, I.
  11. Saura, C.
  12. Sotiriou, C.
  13. Cardoso, F.
  14. Loibl, S.
  15. Andre, F.
  16. Turner, N.C.
Zeitschrift:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Datum der Publikation: 2019

Ausgabe: 30

Nummer: 3

Seiten: 365-373

Art: Rezension

DOI: 10.1093/ANNONC/MDZ036 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus